NEWS COMMENTARY

BioNTech to set up its regional headquarters and an mRNA vaccine manufacturing facility in Singapore

Published:
May 12, 2021
Coverage:
Digital Transformation More...
Activities:
Product More...
Average importance

Pfizer's biotech partner that developed the mRNA vaccine against COVID-19 has moved quickly to ensure it can be elastic in its response to shifting regional and global supply needs for its vaccine given the unpredictable outbreaks in recent times. This move also comes just weeks after Sanofi announced its plans to set up a similar facility in Singapore. Clients can expect more vaccine manufacturers to look for regional sites to not just ramp up production but also leverage local R&D capabilities and digital infrastructure to respond to potentially new variants or new viruses. There is an opportunity to liaise with these manufacturers for regional distribution and joint R&D partnerships in the APAC market.

For the original news article, click here .


Further Reading

EU Commission proposes €10 billion in funding for 10 public-private partnerships to bolster the region's innovation ecosystem

News Commentary | March 04, 2021

The €10 billion will be split across 10 major projects, including healthcare, circular economy, hydrogen, and connectivity technologies. At its core, this is a significant step by the EU to strengthen its leading position in certain areas while also keeping pace with rising competition from around ... Not part of subscription

Dubai's economic agency launches new digital health-focused incubator and accelerator

News Commentary | April 30, 2021

The new incubator and accelerator, called Ztartup, aims to further the role of Dubai as a knowledge center and innovation hub in the region. The Middle East, most notably Saudi Arabia, the United Arab Emirates, and Qatar, has overseen major investments from the government in building R&D ... Not part of subscription

South Korea to invest almost $1 billion to build national digital library of healthcare data by 2028

News Commentary | September 20, 2021

South Korea joins a growing club of countries focusing on national‑level precision medicine projects to combat rising healthcare costs. Like Singapore, it has managed to get buy‑in from a multiministerial taskforce to greenlight this project. It will invest almost $1 billion from 2023 to 2028 to ... Not part of subscription